MD CELL Solution (A Joint-stock Corporation GMC Holdings)


Welcome to the PulseAid listing for the MD CELL Solution drug offered from A Joint-stock Corporation GMC Holdings. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: A Joint-stock Corporation GMC Holdings
NON-PROPRIETARY NAME: Niacinamide, Panthenol, Salicylic Acid
SUBSTANCE NAME: NIACINAMIDE; PANTHENOL; SALICYLIC ACID
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: TOPICAL
DOSAGE FORM: SPRAY
MARKETING CATEGORY NAME: UNAPPROVED DRUG OTHER
START MARKETING DATE: 2016-07-22
END MARKETING DATE: 0000-00-00


MD CELL Solution HUMAN OTC DRUG Details:

Item DescriptionMD CELL Solution from A Joint-stock Corporation GMC Holdings
LABELER NAME: A Joint-stock Corporation GMC Holdings
DEA SCHEDULE:
ACTIVE STRENGTH: .003; .002; .00001(1/100mL; 1/100mL; 1/100mL)
START MARKETING DATE: 2016-07-22
END MARKETING DATE: 0000-00-00
PRODUCT ID: 70834-102_4b16bd52-27f3-4f56-9aec-0148ddf62b5c
PRODUCT NDC: 70834-102
APPLICATION NUMBER:

Other NIACINAMIDE; PANTHENOL; SALICYLIC ACID Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
A Joint-stock Corporation GMC HoldingsMD CELL Solution